Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

March 31, 2006

Conditions
Hypercholesterolemia, FamilialHyperlipidemia
Interventions
DRUG

torcetrapib/atorvastatin

DRUG

atorvastatin

Trial Locations (41)

201

Pfizer Investigational Site, Kopavogur

2050

Pfizer Investigational Site, Camperdown

3168

Pfizer Investigational Site, Clayton

4102

Pfizer Investigational Site, Woolloongabba

5006

Pfizer Investigational Site, North Adelaide

6000

Pfizer Investigational Site, Perth

7500

Pfizer Investigational Site, Parow

7531

Pfizer Investigational Site, Bellville

7925

Pfizer Investigational Site, Cape Town

8000

Pfizer Investigational Site, Arhus C

9000

Pfizer Investigational Site, Aalborg

9301

Pfizer Investigational Site, Bloemfontein

20037

Pfizer Investigational Site, Washington D.C.

21000

Pfizer Investigational Site, Dijon

28204

Pfizer Investigational Site, Charlotte

33549

Pfizer Investigational Site, Lutz

33603

Pfizer Investigational Site, Tampa

44093

Pfizer Investigational Site, Nantes

46260

Pfizer Investigational Site, Indianapolis

52242

Pfizer Investigational Site, Iowa City

53719

Pfizer Investigational Site, Madison

60610

Pfizer Investigational Site, Chicago

77030

Pfizer Investigational Site, Houston

92120

Pfizer Investigational Site, San Diego

96859-5000

Pfizer Investigational Site, Tripler AMC

04210

Pfizer Investigational Site, Auburn

04074

Pfizer Investigational Site, Scarborough

02111

Pfizer Investigational Site, Boston

NSW 2010

Pfizer Investigational Site, Darlinghurst

G7H 5H6

Pfizer Investigational Site, Chicoutimi

H1T 1C8

Pfizer Investigational Site, Montreal

H2W 1R7

Pfizer Investigational Site, Montreal

G1V 4M6

Pfizer Investigational Site, Ste-Foy

75651 Cedex 13

Pfizer Investigational Site, Paris

0027

Pfizer Investigational Site, Oslo

0407

Pfizer Investigational Site, Oslo

413 45

Pfizer Investigational Site, Gothenburg

581 85

Pfizer Investigational Site, Linköping

205 02

Pfizer Investigational Site, Malmo

141 86

Pfizer Investigational Site, Stockholm

Unknown

Pfizer Investigational Site

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00134485 - Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia | Biotech Hunter | Biotech Hunter